These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 15938012)
1. Treatment of brain tumors. Seiter K N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938012 [No Abstract] [Full Text] [Related]
2. Chemotherapy for brain tumors--a new beginning. DeAngelis LM N Engl J Med; 2005 Mar; 352(10):1036-8. PubMed ID: 15758016 [No Abstract] [Full Text] [Related]
3. Treatment of brain tumors. Ashby L; LaRocca R; Ryken T N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938013 [No Abstract] [Full Text] [Related]
4. MGMT gene silencing and benefit from temozolomide in glioblastoma. Hegi ME; Diserens AC; Gorlia T; Hamou MF; de Tribolet N; Weller M; Kros JM; Hainfellner JA; Mason W; Mariani L; Bromberg JE; Hau P; Mirimanoff RO; Cairncross JG; Janzer RC; Stupp R N Engl J Med; 2005 Mar; 352(10):997-1003. PubMed ID: 15758010 [TBL] [Abstract][Full Text] [Related]
5. MSH6 inactivation and emergent temozolomide resistance in human glioblastomas. Cahill DP; Codd PJ; Batchelor TT; Curry WT; Louis DN Clin Neurosurg; 2008; 55():165-71. PubMed ID: 19248684 [No Abstract] [Full Text] [Related]
6. Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT. Fukushima T; Takeshima H; Kataoka H Anticancer Res; 2009 Nov; 29(11):4845-54. PubMed ID: 20032445 [TBL] [Abstract][Full Text] [Related]
7. [Temozolomide in patients with a glioblastoma multiforme: new developments]. Bromberg JE; Postma TJ Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant temozolomide: how long and how much? Franceschi E; Tosoni A; Brandes AA Expert Rev Anticancer Ther; 2008 May; 8(5):663-5. PubMed ID: 18471038 [No Abstract] [Full Text] [Related]
9. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma. Hamilton DA Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911 [No Abstract] [Full Text] [Related]
10. The fallacy of single-agent chemotherapy for cancer. Friedman HS; Maxwell J J Clin Oncol; 2007 Aug; 25(23):3550; author reply 3550-1. PubMed ID: 17687162 [No Abstract] [Full Text] [Related]
11. Going past the data for temozolomide. Villano JL; Letarte N; Bressler LR Cancer Chemother Pharmacol; 2012 Apr; 69(4):1113-5. PubMed ID: 22147076 [TBL] [Abstract][Full Text] [Related]
12. [Glioma therapy up-date]. de la Fuente BP; Dalmau J; Rosenfeld M Neurologia; 2007 Apr; 22(3):159-69. PubMed ID: 17364254 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic radiotherapy for glioblastoma in the elderly. Tartarone A; Ardito R; Romano C N Engl J Med; 2007 Jul; 357(2):196; author reply 196. PubMed ID: 17626310 [No Abstract] [Full Text] [Related]
14. Recurrent PNET with MGMT methylation responds to temozolomide. Oh J; Bilbao JM; Tsao MN; Fazl M; Guiot MC; Del Maestro RF; Perry JR Can J Neurol Sci; 2009 Sep; 36(5):654-7. PubMed ID: 19831139 [No Abstract] [Full Text] [Related]
15. Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients. Quillien V; Lavenu A; Sanson M; Legrain M; Dubus P; Karayan-Tapon L; Mosser J; Ichimura K; Figarella-Branger D J Neurooncol; 2014 Feb; 116(3):487-96. PubMed ID: 24420923 [TBL] [Abstract][Full Text] [Related]
16. Temozolomide in glioblastoma multiforme of the elderly. Brandes AA; Vastola F; Basso U; Pasetto LM; Ermani M; Berti F; Rotilio A; Amistà P; Scienza R; Monfardini S Tumori; 2002; 88(1 Suppl 1):S69-70. PubMed ID: 11989929 [No Abstract] [Full Text] [Related]
17. [Standards and new developments in the chemotherapy of glioblastomas]. Weller M Dtsch Med Wochenschr; 2005 Oct; 130(40):2270-4. PubMed ID: 16208603 [TBL] [Abstract][Full Text] [Related]
18. Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens: is the survival really so impressive?: in regard to Combs et al. (Int J Radiat Oncol Biol Phys 2008;71:999-1005). Jalali R Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1622; author reply 1622-3. PubMed ID: 19028293 [No Abstract] [Full Text] [Related]
19. Taming a mutinous mutant: an errant receptor becomes a prime cancer target. Goldman B J Natl Cancer Inst; 2007 Apr; 99(7):504-5. PubMed ID: 17405993 [No Abstract] [Full Text] [Related]
20. The evolution of chemoradiation for glioblastoma: a modern success story. Mirimanoff RO Curr Oncol Rep; 2006 Jan; 8(1):50-3. PubMed ID: 16464403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]